In this study, we found that it can indirectly assess the degree of intrusion of CD4+T and CD8+T in cancer and paracarcinoma tissues of GC patients via detecting the CD4+T and CD8+T cell numbers present in the surrounding blood, combined with the presence of PD-L1, and the immunotherapy response may be better predicted. This evidence concerns the gene CD8A and cancer.